Notable Mover: Can Zoetis Inc’s Tomorrow Be Different? The Stock Increases Again

Notable Mover: Can Zoetis Inc's Tomorrow Be Different? The Stock Increases Again

The stock of Zoetis Inc (NYSE:ZTS) is a huge mover today! About 1.54M shares traded hands. Zoetis Inc (NYSE:ZTS) has risen 25.95% since March 9, 2016 and is uptrending. It has outperformed by 18.54% the S&P500.
The move comes after 9 months positive chart setup for the $24.62B company. It was reported on Oct, 12 by We have $71.99 PT which if reached, will make NYSE:ZTS worth $9.85 billion more.

Analysts await Zoetis Inc (NYSE:ZTS) to report earnings on November, 1. They expect $0.45 earnings per share, down 10.00% or $0.05 from last year’s $0.5 per share. ZTS’s profit will be $215.46M for 28.57 P/E if the $0.45 EPS becomes a reality. After $0.49 actual earnings per share reported by Zoetis Inc for the previous quarter, Wall Street now forecasts -8.16% negative EPS growth.

Zoetis Inc (NYSE:ZTS) Ratings Coverage

Out of 11 analysts covering Zoetis Inc (NYSE:ZTS), 8 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 73% are positive. Zoetis Inc has been the topic of 20 analyst reports since July 24, 2015 according to StockzIntelligence Inc. Goldman Sachs downgraded the stock to “Sell” rating in Friday, May 6 report. The rating was upgraded by BMO Capital Markets on Friday, September 11 to “Outperform”. The stock has “Buy” rating given by Jefferies on Tuesday, June 14. The rating was maintained by Jefferies with “Buy” on Tuesday, March 15. The firm earned “Buy” rating on Wednesday, June 1 by Stifel Nicolaus. As per Thursday, February 4, the company rating was initiated by Credit Suisse. The stock of Zoetis Inc (NYSE:ZTS) earned “Buy” rating by Zacks on Thursday, September 17. Citigroup maintained Zoetis Inc (NYSE:ZTS) rating on Thursday, August 4. Citigroup has “Neutral” rating and $53 price target. The rating was upgraded by William Blair on Thursday, August 6 to “Outperform”. The firm earned “Buy” rating on Thursday, September 29 by Bank of America.

According to Zacks Investment Research, “Zoetis Inc. is an animal health company. The company discovers, develops, manufactures and markets veterinary vaccines and medicines with a focus on both farm and companion animals. It primarily operates in the United States, Europe, Africa, the Middle East, Canada, Latin America, and the Asia Pacific. Zoetis Inc. is based in Madison, United States.”

Insitutional Activity: The institutional sentiment increased to 1.08 in Q2 2016. Its up 0.15, from 0.93 in 2016Q1. The ratio improved, as 48 funds sold all Zoetis Inc shares owned while 212 reduced positions. 72 funds bought stakes while 210 increased positions. They now own 451.82 million shares or 1.32% less from 457.84 million shares in 2016Q1.
The Minnesota-based Us Fincl Bank De has invested 0.02% in Zoetis Inc (NYSE:ZTS). Advantus Cap Mgmt Inc last reported 44,718 shares in the company. Victory Cap Management last reported 0% of its portfolio in the stock. Glg Prtn L P last reported 0.05% of its portfolio in the stock. Moreover, Grp Inc One Trading Lp has 0% invested in Zoetis Inc (NYSE:ZTS) for 8,286 shares. Products Ltd Co holds 0.54% of its portfolio in Zoetis Inc (NYSE:ZTS) for 144,600 shares. Moreover, Cap Fund Sa has 0.03% invested in Zoetis Inc (NYSE:ZTS) for 67,666 shares. Diligent Investors Limited Co has 28,126 shares for 1.27% of their US portfolio. Moreover, Marsico Capital Mngmt Ltd has 3.47% invested in Zoetis Inc (NYSE:ZTS) for 2.11 million shares. Trexquant Invest Ltd Partnership last reported 0.14% of its portfolio in the stock. The New York-based Lorem Ipsum Management Ltd Limited Liability Company has invested 2.56% in Zoetis Inc (NYSE:ZTS). California State Teachers Retirement System holds 965,380 shares or 0.1% of its portfolio. Veritable L P has invested 0.01% of its portfolio in Zoetis Inc (NYSE:ZTS). New York State Common Retirement Fund has invested 0.09% of its portfolio in Zoetis Inc (NYSE:ZTS). Moreover, United States Steel & Carnegie Pension Fund has 1.39% invested in Zoetis Inc (NYSE:ZTS) for 1.27 million shares.

Insider Transactions: Since May 9, 2016, the stock had 1 buy, and 3 insider sales for $786.61 million net activity. MCCALLISTER MICHAEL B had bought 2,000 shares worth $102,680 on Tuesday, September 6. 16.85M shares with value of $784.37M were sold by Pershing Square Capital Management – L.P. on Monday, May 9. Fenton Andrew sold $710,838 worth of Zoetis Inc (NYSE:ZTS) on Friday, September 2. Shares for $1.64M were sold by Chen Heidi C..

Another recent and important Zoetis Inc (NYSE:ZTS) news was published by which published an article titled: “Zoetis Calls on Outstanding Veterinary Students to Apply for 2017 Scholarships” on October 06, 2016.

ZTS Company Profile

Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Firm has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Firm operates through two divisions: the United States and International. Within each of these divisions, the Company offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment